Billionaire entrepreneur Elon Musk has been the subject of increasing scrutiny in recent years for his reported use of psychedelic drugs and other substances. According to reports from The Wall Street Journal, concerns have been raised by executives and board members at his companies, SpaceX and Tesla. The concerns stem from Musk's behavior and possible use of illicit substances, which potentially pose risks to his health and the future of his business empire. The report indicated that Musk has allegedly engaged in the consumption of LSD, cocaine, ecstasy, and psychedelic mushrooms at private parties worldwide, where attendees were bound by nondisclosure agreements.

Additionally, Musk has admitted to using marijuana in public and claimed to have a prescription for the psychedelic-like drug ketamine to treat depression. A specific incident at an all-hands meeting at SpaceX raised strong concerns among executives about Musk's coherence, with some privately worrying if he was under the influence of drugs. The meeting was described as nonsensical and unhinged, with Musk reportedly slurring his words and speaking incoherently for about 15 minutes before the meeting was taken over by the company's president.

His alleged drug use is a source of worry for executives and board members, particularly at SpaceX, where illicit drug use could jeopardize government contracts due to federal regulations. The report highlights that such drug use could put at risk nearly $1 trillion in assets held by investors, about 13,000 jobs, and the future of the U.S. space program. Furthermore, Musk's behavior, which includes reported intense work schedules, minimal sleep, and occasional outbursts, has led to a series of concerns from board members and executives.

His erratic behavior and drug use have also reportedly resulted in the frustration and resignation of key individuals within his companies. The report also touched on the high-profile incident in 2018 when Musk smoked marijuana on a podcast, leading NASA to insist that SpaceX adhere to federal guidelines on drug use in the workplace and to spend $5 million in taxpayer money to train employees.

This public display of drug use sparked intense scrutiny and further concerns about Musk's judgment and stability. Musk's alleged drug use and unpredictable behavior have significantly impacted his companies, with executives and board members struggling to manage the situation. While Musk's attorney has disputed some of the claims, the mounting evidence and reports suggest that his drug use and erratic behavior pose substantial risks to both his health and his business empire.